These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 688612)

  • 1. Selective purification of tartrate-inhibitable acid phosphatases: rapid and efficient purification (to homogeneity) of human and canine prostatic acid phosphatases.
    Van Etten RL; Saini MS
    Clin Chem; 1978 Sep; 24(9):1525-30. PubMed ID: 688612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractionation and purification of prostatic acid phosphatase.
    Pais VM; Mangold AW; Mahoney SA
    Invest Urol; 1974 Jul; 12(1):13-6. PubMed ID: 4135033
    [No Abstract]   [Full Text] [Related]  

  • 3. Human tartrate-inhibitable lysosomal acid phosphatase. Purification, characterization, biosynthesis and intracellular transport.
    Gieselmann V; Lemansky P; Hasilik A; von Figura K; Waheed A; van Etten RL
    Acta Biochim Pol; 1986; 33(2):119-26. PubMed ID: 3766012
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical significance of tartrate-sensitive and tartrate-resistant acid phosphatase indicated from the study of their biosynthetic mechanism.
    Lam WK; Siemen M; Lee JC; Yam LT; Li CY; Wold LE
    Clin Physiol Biochem; 1987; 5(6):305-14. PubMed ID: 2451579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of homogeneous human prostatic acid phosphatase using concanavalin A-sepharose 4-B.
    Van Etten RL; Saini MS
    Biochim Biophys Acta; 1977 Oct; 484(2):487-92. PubMed ID: 71922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic acid phosphatase: structural aspects of inhibition by L-(+)-tartrate ions.
    Lovelace L; Lewiński K; Jakob CG; Kuciel R; Ostrowski W; Lebioda L
    Acta Biochim Pol; 1997; 44(4):673-8. PubMed ID: 9584847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tartrate-inhibitable acid phosphatase. Purification from placenta, characterization and subcellular distribution in fibroblasts.
    Gieselmann V; Hasilik A; von Figura K
    Hoppe Seylers Z Physiol Chem; 1984 Jun; 365(6):651-60. PubMed ID: 6090300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochemistry and biochemistry of acid phosphatases VII: Immunohistochemistry of canine prostatic acid phosphatase.
    Aumüller G; Vedder H; Enderle-Schmitt U; Seitz J
    Prostate; 1987; 11(1):1-15. PubMed ID: 3658824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acid phosphatases of the human placenta, characterization and immunological comparison with prostatic acid phosphatase.
    Skinningsrud A
    Enzyme; 1983; 29(4):250-9. PubMed ID: 6873037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological characterization of human acid phosphatase gene products.
    Waheed A; Van Etten RL; Gieselmann V; von Figura K
    Biochem Genet; 1985 Apr; 23(3-4):309-19. PubMed ID: 4015620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochemistry and biochemistry of acid phosphatases. III. Inhibition experiments of lysosomal and secretory acid phosphatases of the rat ventral prostate.
    Seitz J; Aumuller G
    Basic Appl Histochem; 1981; 25(2):95-104. PubMed ID: 6455992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of human prostatic acid phosphatase by affinity chromatography and isoelectric focusing. Part I.
    Vihko P; Kontturi M; Korhonen LK
    Clin Chem; 1978 Mar; 24(3):466-70. PubMed ID: 630708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural origins of L(+)-tartrate inhibition of human prostatic acid phosphatase.
    LaCount MW; Handy G; Lebioda L
    J Biol Chem; 1998 Nov; 273(46):30406-9. PubMed ID: 9804805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of prostatic acid phosphatase (PAP) for structural and functional studies.
    Herrala AM; Quintero IB; Vihko PT
    Methods Mol Biol; 2013; 1053():167-78. PubMed ID: 23860655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of human prostatic acid phosphatase and preparation of a specific antiserum in the rabbit.
    Paoli C; Rinaldi F; Tarli P; Neri P
    Ital J Biochem; 1981; 30(3):242-50. PubMed ID: 6792106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and N-terminal sequence of two tartrate-resistant acid phosphatases type-5 from the hairy cell leukemia spleen.
    Stĕpán JJ; Lau KH; Mohan S; Kraenzlin M; Baylink DJ
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1027-34. PubMed ID: 2610679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphotyrosine phosphatase activity of human and canine acid phosphatases of prostatic origin.
    Chevalier S; Landry D; Chapdelaine A
    Prostate; 1988; 12(3):209-19. PubMed ID: 2836832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human prostatic acid phosphatases: I. Isolation.
    Choe BK; Pontes EJ; Bloink S; Rose NR
    Arch Androl; 1978 May; 1(3):221-6. PubMed ID: 83814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the enzymes of Sarcocystis suicanis: purification and characterization of an acid phosphatase.
    Farooqui AA; Adams DD; Hanson WL; Prestwood AK
    J Parasitol; 1987 Aug; 73(4):681-8. PubMed ID: 3114463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and N-terminal amino acid sequence of the tartrate-resistant acid phosphatase from human osteoclastoma: evidence for a single structure.
    Stepan JJ; Lau KH; Mohan S; Singer FR; Baylink DJ
    Biochem Biophys Res Commun; 1990 Apr; 168(2):792-800. PubMed ID: 2334436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.